Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Five Prime Therapeutics Inc (FPRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Five Prime Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Five Prime Therapeutics historical data, for real-time data please try another search
38.00 0.00    0.00%
18/12 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 37.95 - 38.01
Five Prime Therapeutics 38.00 0.00 0.00%

Five Prime Therapeutics Inc Company Profile

 
Get an in-depth profile of Five Prime Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

51

Equity Type

ORD

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of immuno-oncology and targeted cancer therapies. The company’s product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b to treat patients with gastric or gastroesophageal junction and GEJ cancer; FPT155, a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28 that is in Phase Ia/1b clinical trial for patients with solid tumors; and BMS-986258, an anti-T cell immunoglobulin and mucin domain-3 antibody, which is in Phase I/II clinical trial in combination with Opdivo in patients with advanced malignant tumors. Its preclinical programs include FPA157, an anti-CCR8 antibody that is engineered to eliminate CCR8-expressing CD4+ regulatory T cells within solid tumors. It has license and collaboration agreements with Bristol-Myers Squibb Company and Zai Lab (Shanghai) Co., Ltd.; and license agreements with Galaxy Biotech, LLC, and BioWa, Inc. and Lonza Sales AG. The company was founded in 2001 and is headquartered in South San Francisco, California. As of April 16, 2021, Five Prime Therapeutics, Inc. operates as a subsidiary of Amgen Inc.

Contact Information

Address 111 Oyster Point Boulevard
South San Francisco, 94080
United States
Phone 415 365 5600
Fax 415 365 5601
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FPRX Comments

Write your thoughts about Five Prime Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Struggling Tobeathemarket
Struggling Tobeathemarket Nov 19, 2020 4:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I's going back to 5.
Willie Scott
Willie Scott Nov 13, 2020 1:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will it go back to 23?
Ben Dam
Ben Dam Nov 13, 2020 1:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when the dilution is over, usually take some days. When Bio sector come back for gaining, it will follow.
Ben Dam
Ben Dam Nov 13, 2020 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down trend, I got 10 Puts, may be oversold on next week. Time to fill its gaps.
Ben Dam
Ben Dam Nov 12, 2020 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
5,000,000 shares of its common stock in an underwritten public offering in the offering a 30-day option to purchase up to an additional 750,000 shares of common stock offered in the public offering.
Sky Emperor
SkyEmperor Nov 12, 2020 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Article? Link ?
Ben Dam
Ben Dam Nov 12, 2020 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sky Emperor  offering price is $21 just posted today. Do your own DD. I will try to do but been busy today
Ben Dam
Ben Dam Nov 12, 2020 1:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sky Emperor  https://finance.yahoo.com/news/five-prime-announces-pricing-upsized-030000081.html
Ben Dam
Ben Dam Nov 12, 2020 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nov 11th, my bad.
Ben Dam
Ben Dam Nov 12, 2020 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Offering was yesterday Nov 10th - 5 Mil = 750,000 shares within 30 days, dilution.
Ben Dam
Ben Dam Nov 12, 2020 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to drop, also offering can happen anytime by now.
Tarek Sherif
Tarek Sherif Nov 12, 2020 9:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Short or you’ll miss
Abdul Basheer
Abdul Basheer Nov 12, 2020 9:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yesterday i shorted and loss also bettertoshort @30
Fatma Argün
Fatma Argün Nov 11, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The news about the biontech vaccine is said to be false.
Petros Dinalis
PetrosMT Nov 11, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Link please?
george diolitsis
george diolitsis Nov 11, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ha ha they don't make vaccines petros...she is confused they have a medicine against cancer
Sky Emperor
SkyEmperor Nov 11, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Such a strong statement needs link and facts that is not the competition trying to under mine it
george diolitsis
george diolitsis Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ok I bought 40 shares at 18....just for fun....ha ha
Show previous replies (10)
george diolitsis
george diolitsis Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
petro me poia etairia mporeis kai paizeis premarket? ego me DE HIRO den mporo. den exoyn eksoysiodotisi gia premarket
Petros Dinalis
PetrosMT Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kalispera syggnomi pou argisa alla sto kinito den erxetai eidopoiisi. Monos mou tsekara to thread KAI eida tin erotisi sou.
Petros Dinalis
PetrosMT Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Den ksero KATHOLOU tin "DE HIRO". paizo me eurobank equities (den exein pre) KAI me tin exante (exei). Exo filo pou tin antiprosopeyei ellada an thes na sas fero se epafi.
Petros Dinalis
PetrosMT Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ypotheto itheles na peis "degiro". Episis me tin empeiria mou OS tora me agores poliseis pre / after. Den to synisto. 1 kerdizeis 10 xaneis. Se pre/after Mia megali paraggelia allazei dramatika tin timi.
Petros Dinalis
PetrosMT Nov 11, 2020 11:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kali Ora simera itan oli I texnologia Kato sto pre KAI o nasdaq arnitikos. Sto anoigma gyrisan Ola ta xartia thetika. Exo poulisei etsi pre kai mou pige apo -3% pre se +7% synedriasi
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email